Articles tagged "Kidney/pancreas transplantation"

2018 American Transplant Congress
De Novo DSA against Third Party Extension Vessels Used in Kidney and Pancreas Transplantation
N. Garg, T. Ellis, R. Redfield, S. Parajuli, B. Astor, A. Djamali, D. Mandelbrot.
University of Wisconsin, Madison.
Third party ABO-compatible vessel allografts (VA) are sometimes used as extension vessels for kidney and pancreas transplants (TX). The frequency and implications of de novo…
2018 American Transplant Congress
Robotic Pancreas Transplantation in Obese Recipients: Preliminary Results
M. Spaggiari,¹ C. Di Bella,¹ P. Di Cocco,¹ F. Gheza,¹ E. Benedetti,¹ I. Tzvetanov,¹ J. Oberholzer.²
¹Surgery, University of Illinois, Chicago, IL; ²Surgery, University of Virginia, Virginia, VA.
IntroductionObesity is considered a relative contraindication to pancreas transplantation due to increased risks of wound and surgical related complications. Robotic surgery has never been applied…
2018 American Transplant Congress
Declining Number of Pancreas after Kidney Transplants Despite Significant Improvement in Outcome
A. Gruessner,¹ M. Laftavi,² O. Pankewycz,² R. Gruessner.¹
¹SUNY Downstate Medical Center, Brooklyn, NY; ²SUNY Upstate Medical University, Syracuse, NY.
Introduction: The number of whole organ pancreas transplants declined significantly over the past 15 years. The largest decrease was seen in pancreas after kidney (PAK)…
2018 American Transplant Congress
Morphometric and Metabolic Correlates of Frailty in Pancreas Transplant Recipients
R. Parsons, J. Wolosyn, R. Lynch.
Surgery, Emory University, Atlanta, GA.
Background: Prediction of survival and health resource utilization in the pancreas transplant population requires novel approaches to risk stratification. We studied whether sarcopenia and osteopenia,…
2018 American Transplant Congress
Provision of Highly Specialized Aftercare by the Transplant Center Strongly Improves Patient, Pancreas and Kidney Allograft Survival in Long-Term Follow-Up after Simultaneous Pancreas-Kidney Transplantation
T. Schachtner,^1,2,3 M. Zaks,¹ A. Kahl,¹ P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany; ³Berlin Institute of Health BIH, Charite and Max Delbrueck Center, Berlin, Germany.
Despite rapid medical advancements in the field of transplantation, mean allograft survival remained at a standstill. If and to what extent a highly specialized and…
2018 American Transplant Congress
Evolutive Analysis of a 20-Year Pancreas Transplant Program
M. Perosa,¹ J. Branez,¹ L. Mota,¹ H. Noujaim,¹ B. Zeballos,¹ L. Ianhez,¹ L. Alvim,¹ D. Machado,¹ C. Watanabe,¹ F. Sergi,¹ M. Paredes,¹ T. Genzini-Miranda,² A. Silvestre,³ G. Martinho,⁴ T. Genzini.¹
¹Abdominal Organ Transplantation, Leforte Hospital, Sao Paulo, Brazil; ²Medical School, PUC Sorocaba, Sorocaba, Sao Paulo, Brazil; ³Medical School, Sao Camilo, Sao Paulo, Brazil; ⁴Medical School, Ciências Médicas Santa Casa, Sao Paulo, Brazil.
There is a worldwide trend towards a reduction in the annual number of pancreas transplants (PT). In Brazil, only two centers have performed more than…
2018 American Transplant Congress
Experience with Alemtuzumab Induction with Tacrolimus/Mycophenolate +/- Steroids in Simultaneous Pancreas-Kidney Transplant Recipients with Portal-Enteric Drainage
D. Harriman, A. Farney, J. Rogers, G. Orlando, A. Reeves-Daniel, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta.
Surgery, Medicine, Pathology, Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC.
Introduction: Simultaneous pancreas-kidney transplant (SPKT) recipients are a relatively homogeneous population that are considered high immunological risk because of younger age, presumed autoimmune etiology of…
2017 American Transplant Congress
Factors in Association with Sepsis Differ Between Simultaneous Pancreas/Kidney and Single Kidney Transplant Recipients.
T. Schachtner,^1,2,3 M. Zaks,¹ A. Kahl,¹ P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany; ³Charite and Max-Delbrück Center, Berlin Institute of Health BIH, Berlin, Germany
As immunosuppressive therapy and allograft survival have improved in simultaneous pancreas/kidney transplant recipients (SPKTRs), the increased incidence of infection has become a major hurdle of…
2017 American Transplant Congress
The Incidence and Outcomes of Fever of Unknown Origin After Pancreas Transplantation.
R. Klasek,¹ S. Kuten,¹ S. Patel,^1,3 D. Nguyen,¹ E. Graviss,¹ A. Gaber,¹ R. Knight.¹
¹Houston Methodist Hospital, Houston, TX; ²Veloxis Pharmaceuticals, Cary, NC
Previous studies have shown that approximately 20% of febrile episodes in transplant recipients are not associated with infection. At our center, fever of unknown origin…
2017 American Transplant Congress
Impact of Pancreas Transplant Failure in Quality of Life in Simultaneous Kidney Pancreas Transplantation.
B. Alharbi, S. Aquil, H. Sharma, O. Ali, P. Luke, A. Sener.
Departments of Surgery and Microbiology and Immunology, Matthew Mailing Center for Translational Transplant Studies, Western University, London, London, ON, Canada
BackgroundBoth kidney and pancreas transplantation have been shown to be associated with improved quality of life (QoL). In fact, one of the most important outcomes…